Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.

@article{JimnezQuevedo2007LongtermCB,
  title={Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.},
  author={Pilar Jim{\'e}nez-Quevedo and Manel Sabat{\'e} and Dominick Joseph Angiolillo and Fernando Alfonso and Rosa Ana Hern{\'a}ndez-Antol{\'i}n and Marcelo Sanmart{\'i}n and Joan Antoni G{\'o}mez-Hospital and Cami{\~n}o Ba{\~n}uelos and Javier Escaned and Ra{\'u}l Moreno and Cristina Fernandez and Francisco Fernandez-Aviles and Carlos M Macaya},
  journal={European heart journal},
  year={2007},
  volume={28 16},
  pages={1946-52}
}
AIMS Sirolimus stent implantation has been demonstrated to be safe and effective in diabetics; however, the long-term outcomes in this high-risk population remain unknown. The aim of this study was to determine the long-term safety and efficacy of the sirolimus-eluting stent (SES) when compared with the bare metal stent (BMS) in patients included in the DIABETES (DIABETes and sirolimus Eluting Stent) trial. METHODS AND RESULTS The prospective multicentre DIABETES trial randomized 160 diabetic… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 27 extracted citations

Factors associated with deferred lesion failure following fractional flow reserve assessment in patients with diabetes mellitus.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions • 2017
View 1 Excerpt

Similar Papers

Loading similar papers…